Danaher Corporation which can be found using ticker (DHR) now have 24 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The target price High/Low ranges between $315.00 and $255.00 and has a mean share price target at $289.42. (at the time of writing). Now with the previous closing price of $241.53 this would imply there is now a potential upside of 19.8%. Also worth taking note is the 50 day moving average now sits at $262.89 and the 200 moving average now moves to $256.89. The company has a market cap of 172.90B. The stock price is currently at: $239.38 USD
The potential market cap would be $207,180,636,712 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 45.25, revenue per share of $32.29 and a 3.86% return on assets.
Danaher Corporation designs, manufactures and markets professional, medical, industrial, and commercial products and services. The Company’s segments include Biotechnology, which includes the bioprocessing and discovery and medical businesses and offers a range of tools, consumables and services; Life Sciences segment, which offers a range of instruments and consumables that are primarily used by customers to study the basic building blocks of life, including genes, proteins, metabolites, and cells, to understand the causes of disease, identify new therapies, and test and manufacture new drugs and vaccines; Diagnostics segment that offers clinical instruments, reagents, consumables, software, and services that hospitals, physicians’ offices, reference laboratories, and other critical care settings use to diagnose disease, and Environmental & Applied Solutions segment, which offers products and services that help protect precious resources and keep global food and water supplies safe.
